MD406C2 - Compound for prophilaxis of sexually transmetted deseases and vaginal tampon for prohylaxis thereof - Google Patents

Compound for prophilaxis of sexually transmetted deseases and vaginal tampon for prohylaxis thereof

Info

Publication number
MD406C2
MD406C2 MD95-0089A MD950089A MD406C2 MD 406 C2 MD406 C2 MD 406C2 MD 950089 A MD950089 A MD 950089A MD 406 C2 MD406 C2 MD 406C2
Authority
MD
Moldova
Prior art keywords
compound
deseases
sexually
transmetted
prophilaxis
Prior art date
Application number
MD95-0089A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Augros Jacques
Original Assignee
Sspl Safe Sex Products Licensing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sspl Safe Sex Products Licensing filed Critical Sspl Safe Sex Products Licensing
Publication of MD406C2 publication Critical patent/MD406C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

The present invention relates to prevention of the sexually transmitted deseases, e.g. AIDS.The compound contains the active antiviral or antibacterial substance, retarder of active substance penetration through the mucous membrane and therapeutically admitted filler.The vaginal tampon is made of foam material, impregnated with this compound.
MD95-0089A 1988-07-11 1994-12-30 Compound for prophilaxis of sexually transmetted deseases and vaginal tampon for prohylaxis thereof MD406C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809418 1988-07-11

Publications (1)

Publication Number Publication Date
MD406C2 true MD406C2 (en) 1996-06-30

Family

ID=9368330

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0089A MD406C2 (en) 1988-07-11 1994-12-30 Compound for prophilaxis of sexually transmetted deseases and vaginal tampon for prohylaxis thereof

Country Status (38)

Country Link
US (1) US5439685A (en)
EP (1) EP0351301B1 (en)
JP (1) JPH0774164B2 (en)
KR (1) KR0143231B1 (en)
CN (1) CN1035038C (en)
AP (1) AP108A (en)
AR (1) AR243381A1 (en)
AT (1) ATE97570T1 (en)
BR (1) BR8903523A (en)
CA (1) CA1341304C (en)
CZ (1) CZ280722B6 (en)
DD (1) DD283932A5 (en)
DE (1) DE68910892T2 (en)
DK (1) DK173527B1 (en)
ES (1) ES2062065T3 (en)
FI (1) FI101595B (en)
HK (1) HK131095A (en)
HU (1) HU206634B (en)
IE (1) IE63115B1 (en)
IL (1) IL90910A (en)
LT (1) LT3754B (en)
LV (1) LV10573B (en)
MA (1) MA22036A1 (en)
MD (1) MD406C2 (en)
MX (1) MX170801B (en)
MY (1) MY106242A (en)
NO (1) NO178843C (en)
NZ (1) NZ229891A (en)
OA (1) OA09123A (en)
PL (1) PL161848B1 (en)
PT (1) PT91108B (en)
RU (1) RU2065742C1 (en)
SK (1) SK423889A3 (en)
TN (1) TNSN89074A1 (en)
TR (1) TR28353A (en)
UA (1) UA26124A (en)
YU (1) YU47899B (en)
ZA (1) ZA895263B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02258718A (en) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd Pasty base and pharmaceutical
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
IT1255450B (en) * 1992-06-30 1995-10-31 Montefarmaco Spa USE OF BILE ACIDS AS ANTI-VIRAL AGENTS
WO1995003056A1 (en) * 1993-07-19 1995-02-02 Tokyo Tanabe Company Limited Hepatitis c virus proliferation inhibitor
DE4341139C1 (en) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimethicone for the treatment of aphthae
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
GB2318292A (en) * 1996-09-12 1998-04-22 Simon Everard Barton Saliva-like protectants
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
AU4343101A (en) * 2000-03-07 2001-09-17 Rush Presbyterian St Luke Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
US8093446B2 (en) * 2001-04-11 2012-01-10 Playtex Products, Inc. Fibrous absorbent articles having malodor counteractant
GB2415626B (en) * 2001-04-11 2006-03-08 Playtex Products Inc Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor
GB2414394B (en) * 2001-04-11 2006-01-11 Playtex Products Inc Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour
EP1506781B1 (en) * 2003-11-03 2005-02-23 Peter-Hansen Volkmann Vaginal care composition
RU2391985C2 (en) * 2005-08-29 2010-06-20 СЕПСИКУРЕ ЭлЭлСи Treatment and prevention method of gram-positive bacteria induced diseases
DE102006020644A1 (en) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Silicone elastomer containing homogeneously dispersed, micronized antiseptic, e.g. chlorhexidine, octenidine or triclosan, used for the production of plastic medical articles, especially catheters
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8062631B2 (en) * 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
AU2012203566B1 (en) * 2008-03-27 2013-09-12 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
KR101130754B1 (en) 2010-06-25 2012-03-28 제일약품주식회사 Pharmaceutical compositions having improved solubility of poorly soluble tricyclic derivative compounds
MX339735B (en) 2010-11-12 2016-06-07 The Univ Of Utah Res Found Intravaginal devices for controlled delivery of lubricants.
CN103619341A (en) 2011-04-19 2014-03-05 Arms制药有限公司 Method of inhibiting harmful microorganisms and barrier-forming composition therefor
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
KR102399883B1 (en) * 2021-02-09 2022-05-20 재단법인대구경북과학기술원 Composite polymer pellets for extrusion and manufacturing method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113998A2 (en) * 1982-12-22 1984-07-25 Herpes Pharmaceutical, Inc. Composition and treatment for herpes simplex viral infections

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161484A (en) * 1965-08-20 1969-08-13 Mediline Ag Toilet Preparation
SE353658B (en) * 1967-06-13 1973-02-12 Dow Corning
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE791632A (en) * 1971-11-20 1973-05-21 Schering Ag SILICONIC RUBBER-BASED SUPPORTS FOR MEDICINAL PRODUCTS
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4228797A (en) * 1978-09-25 1980-10-21 Dickey Richard P Intravaginal contraception method
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
AU9131982A (en) * 1981-12-07 1983-06-16 Syntex (U.S.A.) Inc. Contraceptive device releasing 1-substituted imadazoles
DE3204124A1 (en) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC TAMPONS WITH HIGH ACTIVE SUBSTANCE RELEASE
DE3346641A1 (en) * 1983-12-23 1985-07-04 Dynamit Nobel Ag, 5210 Troisdorf Silane-modified ester mixture
GB8402748D0 (en) * 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
NL8600929A (en) * 1986-04-11 1987-11-02 Fundatech Sa METHOD FOR MANUFACTURING MEDICATED DISPOSABLE PESSARIES AND MEDICATED DISPOSABLE PESSARIES
IT1213323B (en) * 1986-08-07 1989-12-20 Crinos Industria Farmaco COMPOSITION FOR LOCAL USE WITH ACTS VIRULICIDE, DISINFECTANT AND / OR BACTERICIDE SPERMICIDE
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
FR2614525B1 (en) * 1987-04-29 1995-11-10 Jacques Augros ELASTIC SPONGE PAD, ESPECIALLY VAGINAL PAD
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113998A2 (en) * 1982-12-22 1984-07-25 Herpes Pharmaceutical, Inc. Composition and treatment for herpes simplex viral infections

Also Published As

Publication number Publication date
IE892218L (en) 1990-01-11
ATE97570T1 (en) 1993-12-15
CZ423889A3 (en) 1995-12-13
PL161848B1 (en) 1993-08-31
PL280531A1 (en) 1990-05-28
KR900001366A (en) 1990-02-27
BR8903523A (en) 1991-11-05
AP8900133A0 (en) 1989-10-31
MA22036A1 (en) 1991-10-01
NO178843C (en) 1996-06-19
AU3802689A (en) 1990-01-11
SK278614B6 (en) 1997-11-05
DK173527B1 (en) 2001-01-29
HK131095A (en) 1995-08-24
AP108A (en) 1991-02-23
MX170801B (en) 1993-09-14
KR0143231B1 (en) 1998-07-15
YU135789A (en) 1992-05-28
JPH0774164B2 (en) 1995-08-09
RU2065742C1 (en) 1996-08-27
AR243381A1 (en) 1993-08-31
UA26124A (en) 1999-06-07
HUT50445A (en) 1990-02-28
FI101595B1 (en) 1998-07-31
EP0351301A2 (en) 1990-01-17
PT91108B (en) 1995-01-31
DK340289D0 (en) 1989-07-10
AU625716B2 (en) 1992-07-16
JPH02167235A (en) 1990-06-27
NO892826D0 (en) 1989-07-07
CN1035038C (en) 1997-06-04
NO178843B (en) 1996-03-11
DE68910892D1 (en) 1994-01-05
TNSN89074A1 (en) 1991-02-04
IE63115B1 (en) 1995-03-22
CZ280722B6 (en) 1996-04-17
IL90910A0 (en) 1990-02-09
DD283932A5 (en) 1990-10-31
LV10573B (en) 1995-08-20
CN1041879A (en) 1990-05-09
FI893340A (en) 1990-01-12
TR28353A (en) 1996-05-16
ZA895263B (en) 1991-03-27
IL90910A (en) 1994-12-29
LV10573A (en) 1995-04-20
OA09123A (en) 1991-10-31
LTIP1660A (en) 1995-07-25
ES2062065T3 (en) 1994-12-16
CA1341304C (en) 2001-10-09
SK423889A3 (en) 1997-11-05
HU206634B (en) 1992-12-28
EP0351301A3 (en) 1990-12-19
LT3754B (en) 1996-03-25
FI893340A0 (en) 1989-07-10
DK340289A (en) 1990-01-12
YU47899B (en) 1996-05-20
NO892826L (en) 1990-01-12
FI101595B (en) 1998-07-31
NZ229891A (en) 1991-01-29
US5439685A (en) 1995-08-08
MY106242A (en) 1995-04-29
PT91108A (en) 1990-02-08
EP0351301B1 (en) 1993-11-24
DE68910892T2 (en) 1994-05-05

Similar Documents

Publication Publication Date Title
MD406C2 (en) Compound for prophilaxis of sexually transmetted deseases and vaginal tampon for prohylaxis thereof
IE42345L (en) Vaginal ring
IE800117L (en) Depot body on the basis of silicone rubber for sustained¹drug release
AU697311B2 (en) Combined preparation for the therapy of immunological diseases
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
EG17996A (en) Benzimidazole derivative,process for its preparation,and insecticidal and/or acaricidal composition containing it as an active ingredient
EG18379A (en) Novel pharmacological compounds
DE3577806D1 (en) TRANSDERMAL DELIVERY DEVICES.
AU8436401A (en) Methods and pharmaceutical compositions for healing wounds
JPS56500495A (en)
ATE68686T1 (en) SYSTEM FOR RELEASING SUBSTANCES IN THE VAGINA.
JPS5218813A (en) Plasters for the relief of cutaneous diseases
AP9801306A0 (en) Contraceptive release system with an antibacterial action and/or antiviral action.
AU591046B2 (en) Physiologically active agent for agricultural use
EP0287204A3 (en) Silver sulfadiazine useful for inhibiting the transmission of the aids virus
AU6228580A (en) Use of psychoactive drugs as vaginal contraceptives
MY106036A (en) Preventing agent for human immunodeficiency virus infection comprising menfegol.
YU13599A (en) Use of pharmaceutical composition for preparation of medicament in a gel form
IL82937A0 (en) Pyrrolinylacetamide,processes for the preparation thereof and the use thereof
JPS6471814A (en) Useikokashooshochisurutamenoiyakusoseibutsu
UA19674A (en) Composition for treating contact lenses
DE69709891T2 (en) COMPOSITION CONTAINING CHITOSAN
MD1051C2 (en) Antiherpetic remedy
AU555285B2 (en) Gestagenically active 11beta-chloro-delta15-steroids
EP0127076A3 (en) Histargin, a microbiological process for its preparation, its use as a medicament, and the strain streptomyces roseoviridis having the ability to produce histargin